Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Talos Integrates with STS Digital to Bring Institutional Crypto Options and Spot Liquidity to its Provider Network

    August 5, 2026

    OECD inflation eases to 4.2% as lower energy rates take hold

    August 5, 2026

    Oil prices fall as Brent and WTI reach three-week lows again

    August 5, 2026
    Turkmenia NewsTurkmenia News
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Turkmenia NewsTurkmenia News
    Home » Maypharm’s Hyalmass filler with Hybrid Technology obtained CE to hit Europe and America’s market
    PR Newswire

    Maypharm’s Hyalmass filler with Hybrid Technology obtained CE to hit Europe and America’s market

    April 18, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SEOUL, South Korea and NEW YORK, April 18, 2023 /PRNewswire/ — Being already popular on South Asia market, particularly in Vietnam, Philippines, Thailand, China, for Hybrid Technology and highly dense HA for long-lasting effect, Hyalmass filler obtains CE to properly enter Europe, America etc markets.

    Along with Metoo fill, Sedy fill, Metox, Mennus, Hairna and Eyebella, Hyalmass has passed a ton of exacting clinical preliminaries to guarantee device’s performance. It was developed by adding a local anaesthetic lidocaine to lessen pain during the procedure. It also contains a soft tissue material hyaluronic acid and aimed at temporary improvement of wrinkles. Hyalmass is made of a homogenized hyaluronic acid, which is Maypharm’s own product that creates a high bio-compatibility rate.

    Hyalmass is a cosmetic treatment that aims to restore volume and smooth out wrinkles in the face. This procedure is performed using hyaluronic acid, a naturally occurring substance in the body that provides hydration and fullness to the skin.

    Unique push rod of Hyalmass was designed to enable the user to insert it for the procedure with less effort. The handle design is specially developed to fit various sizes of hands and prevent from slipping.

    Maypharm’s Hyalmass filler

    Main benefit of using Hyalmass filler is immediate and noticeable results. After the treatment, patients can expect to see an improvement in the appearance of wrinkles, fine lines, and sagging skin, as well as an increase in overall facial volume. The results can last for up to 12 months and the treatment is safe and effective for most people.

    In addition to its cosmetic benefits, the Hyalmass filler can also have a positive impact on a person’s confidence and self-esteem. By restoring volume and smoothing out wrinkles, patients can feel more youthful and refreshed, which can lead to an improvement in their overall well-being.

    In conclusion, Hyalmass filler is a popular cosmetic treatment that offers a simple and effective solution for restoring volume and smoothing out wrinkles in the face. Whether you look forward to improving your appearance or boosting your confidence, this treatment is the best option to consider.

    Maypharm is looking forward to becoming well-known manufacturer of dermal fillers for their safety and efficiency, and being on highest demand on every market, Asia, Middle East and Africa or South and North America.

    Maypharm’s Hyalmass filler

    Visit the website for detailed information: http://www.maypharm.net

    Photo – https://mma.prnewswire.com/media/2056663/Maypharm_s_Hyalmass_filler.jpg
    Photo – https://mma.prnewswire.com/media/2056664/Maypharm_s_Hyalmass_filler.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/maypharms-hyalmass-filler-with-hybrid-technology-obtained-ce-to-hit-europe-and-americas-market-301800102.html

    Related Posts

    Global luxury market contracts for first time since Great Recession

    November 18, 2024

    Ginger emerges as leading spice for blood sugar management

    April 4, 2024

    ICBA: Aspartame safe, reaffirm WHO and FAO

    July 14, 2023

    Casio to Release First Collaboration EDIFICE with MUGEN

    July 13, 2023

    Atlas Corp.’s 2022 Sustainability Report: Embedded ESG Values Drive Decision Making

    July 12, 2023

    SANY 2023: Fostering First-Class Talents for the Future of Manufacturing Industries

    July 12, 2023
    Latest News

    OECD inflation eases to 4.2% as lower energy rates take hold

    August 5, 2026

    Oil prices fall as Brent and WTI reach three-week lows again

    August 5, 2026

    Moderna begins Ebola vaccine trial amid DR Congo outbreak

    August 5, 2026

    Guatemala raises red alert as Fuego volcano erupts

    August 5, 2026

    Eastern Washington fires leave 700 structures destroyed

    August 4, 2026

    Michigan reports first deaths tied to cyclospora outbreak

    August 4, 2026

    Oil prices swing after Brent tops $90 on supply strains

    August 3, 2026

    DR Congo Ebola outbreak reaches record scale

    August 3, 2026
    © 2026 Turkmenia News | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.